· Intro: definitions and significance
· Central nervous system
· Peripheral nervous system
· Autonomic nervous system
Pain |
· Unpleasant sensory and emotional experience associated with actual or potential tissue damage or is described in such terms |
Ageing |
· Gradual time-dependent loss of cellular function and physiological reserve, resulting in death |
Summary |
· ↓Nociceptive response to noxious stimuli · ↑Susceptible to analgesic toxicity · ↓Ability to communicate · Frequently undertreated |
Changes |
· ↓Grey matter: o ↓10,000 neurons per day from age 20 o Total 10% loss by age 80 · ↓White matter (less affected) · ↓Neurotransmitters: o ↓Serotonin and noradrenaline (+/-depression) o ↓Dopamine in substantia nigra (+/-Parkinson’s disease) o ↓Acetylcholine in hypothalamus (+/-senile dementia) |
Effect on pain |
· ↓Cognition · ↓Communication of pain · ↓Reflex speed -> slower withdrawal from insult · ↓Activity of endogenous analgesic pathways |
Disease |
· Dementia and delirium common · Inability to communicate · Pain perception preserved |
Changes |
· Generally less affected · ↓Neurons · ↓Axons (myelinated and not) · ↓Synapses · ↓Neurotransmitters (substance P, CGRP) |
Effect on pain |
· ↓Nociceptive afferents · ↓Sensitisation · ↓Speed of conduction |
Disease |
· ↑Risk diabetes, +/- peripheral neuropathy -> ↓ pain e.g. toe amputation |
Changes |
· ↓Cardiac β1 adrenoceptors · ↓post-adrenoceptor signalling · (↑Circulating noradrenaline partly offsets above) |
Effect on pain |
· ↓Autonomic response to pain · Risk of undertreatment intra-op |
Drugs |
· β-blockers commonly prescribed -> attenuates HR response -> risk of undertreatment |
Feedback welcome at ketaminenightmares@gmail.com